Setting new standards in information exchange for the pharmaceutical and biotech industry

Intrinsic Editing vs Systemic Combination Debate
-
December 23, 2020
-
In this podcast first recorded at the 2020 IO360° Summit, Dr Aiman Shalabi, GSK, moderated a cell and gene therapy debate on intrinsic editing vs systemic combination
Participants included:
- Mark O’Hara, MD, University of Pennsylvania
- Saul Priceman, PhD, City of Hope